Modern life science laboratories are under constant pressure to generate reliable data faster, improve reproducibility, and streamline increasingly complex workflows. From ELISA automation and nucleic acid quantification to high-throughput screening and live-cell analysis, selecting the right liquid handling and detection platform can significantly improve laboratory efficiency. 

Agilent’s liquid handling and microplate instrumentation portfolio combines flexible automation, multimode detection, plate washing, dispensing, and workflow integration technologies designed to support research laboratories ranging from routine assay environments through to advanced high-throughput screening facilities. 

Agilent offers a broad range of workflow solutions that help laboratories: 

• Reduce manual pipetting and repetitive handling  

• Improve assay consistency and reproducibility  

• Scale from low-throughput to automated high-throughput workflows  

• Support applications including ELISA, cell-based assays, nucleic acid quantification, microbial kinetics, phenotypic screening, and organoid workflows  

• Integrate automation across washing, dispensing, detection, and plate handling  

Agilent absorbance readers support routine laboratory workflows including ELISAs, protein assays, microbial growth studies, and nucleic acid quantification.  

Agilent 800 TS Microplate Reader 

The 800 TS is designed for straightforward absorbance workflows and cost-conscious laboratories requiring reliable performance for routine assays. 

Key features 

• Reads wavelengths from 400-750 nm  

• Supports 6- to 384-well plates  

• Touchscreen interface with USB export  

• Optional temperature control and shaking  

• Gen5 software integration  

Best-fit applications: ELISAs, Protein assays, Enzyme kinetics, Basic cell-based assays  

Agilent Epoch Microplate Spectrophotometer 

The Epoch combines monochromator-based UV-Vis detection with flexible wavelength selection for nucleic acid and protein quantification workflows.  

Key features 

• UV-Vis range from 200-999 nm  

• Compatible with Take3 micro-volume plates  

• Temperature control to 65 °C  

• Supports 6- to 384-well plates  

Best-fit applications: DNA and RNA quantification, 260/280 and 260/230 purity measurements, Cytotoxicity assays, Cell proliferation studies, Enzyme kinetics  

Agilent Epoch 2 Microplate Spectrophotometer 

The Epoch 2 expands absorbance capabilities with stand-alone touchscreen operation and full-spectrum scanning functionality.  

Ideal for: Spectral scanning, Microbial growth kinetics, Nucleic acid purity analysis, Stand-alone absorbance workflows  

Reliable washing is critical for reducing background noise and improving assay consistency in ELISA and cell-based workflows. 

Agilent 50 TS Washer 

The 50 TS provides dependable automated washing for routine assays and pairs naturally with absorbance readers like the 800 TS.  

Applications: ELISA washing, Cell-based assays, Vacuum filtration workflows 

Agilent 405 LS and 405 TS Washers 

These automated plate washers support more advanced workflows with dual-action manifold technology and automation compatibility.  

Key features 

• Automated washing for 96- and 384-well plates  

• Biomagnetic separation support  

• Vacuum filtration modules  

• Four-buffer switching  

• BioStack automation compatibility  

Best-fit workflows: ELISA, Microsphere-based assays, Automated cell-based assays  

Combining washing and dispensing into a single platform can simplify workflows and reduce instrument footprint. 

Agilent 406 FX Washer Dispenser 

The 406 FX integrates washing and dispensing capabilities for automated multi-step assay workflows.  

Highlights 

• Washing plus up to six reagent dispensers  

• Supports biomagnetic protocols  

• Compatible with 96- to 1536-well plates  

• Robotic integration support  

Common applications: ELISA automation, Cell culture workflows, Bead-based assays  

Agilent EL406 Washer Dispenser 

The EL406 combines rapid washing and dispensing into a compact automation-ready platform.  

Ideal for: High-throughput ELISA workflows, Multiplex assays, Integrated wash and dispense automation  

Agilent MultiFlo FX Multi-Mode Dispenser 

The MultiFlo FX is designed for flexible reagent dispensing across a wide range of assay formats.  

Key capabilities 

• Dispensing to 6- to 1536-well plates  

• Up to four reagents in parallel  

• Gentle media exchange options for delicate cultures  

Applications: 2D and 3D cell culture, Spheroid and organoid workflows, ELISA preparation, Bead-based assays  

Agilent multimode readers combine absorbance, fluorescence, and luminescence detection technologies to support a broad range of assay requirements. 

Agilent Synergy Neo2 

The Synergy Neo2 is designed for demanding high-throughput and multiplex workflows.  

Features 

• Hybrid detection with filter and monochromator optics  

• Laser TRF capability  

• Up to four PMTs  

• Environmental control with CO₂/O₂ regulation  

Applications: High-throughput screening, Multiplex assays, Advanced multimode workflows 

Agilent Synergy HTX 

The Synergy HTX provides economical multimode detection for routine assay environments.  

Detection modes: Absorbance, Fluorescence, Luminescence, Alpha assays  

Agilent Synergy LX 

The Synergy LX is designed for straightforward multimode detection with an intuitive touchscreen interface.  

Ideal applications: Nucleic acid quantification, ELISA, BCA and Bradford assays, Cell viability workflows  

Agilent Synergy H1 

The modular Synergy H1 platform enables laboratories to scale capabilities as assay requirements evolve.  

Supports: Absorbance, Fluorescence, Luminescence, AlphaScreen, TRF workflows  

Agilent Cytation 9 

The Cytation 9 combines automated imaging with multimode detection in a single platform.  

Key capabilities 

• Imaging up to 60× magnification  

• Fluorescence, luminescence, and UV-Vis detection  

• Live-cell environmental control to 65 °C

• BioStack automation compatibility  

Common applications: Live-cell imaging, Phenotypic screening, Quantitative cell analysis

Agilent BioStack 

The BioStack automates plate loading and unloading for walk-away workflow automation.  

Benefits 

• Fast plate exchange  

• Delidding and re-lidding support  

• Compatible with 6- to 1536-well plates  

• Enables unattended high-throughput processing  

Agilent’s liquid handling and microplate instrumentation portfolio supports a wide spectrum of laboratory applications, from routine absorbance assays through to advanced automation and high-content workflows. With scalable solutions for washing, dispensing, detection, imaging, and plate automation, laboratories can build flexible workflows that improve reproducibility, efficiency, and throughput.  

To discuss the best Agilent liquid handling workflow for your laboratory, contact the team at Millennium Science. 

Clinical research is increasingly driven by the need to understand biological heterogeneity, identify actionable biomarkers, and link molecular mechanisms to patient outcomes. Traditional bulk and low-resolution approaches often mask clinically relevant signals, slowing discovery and translation. 10x Genomics technologies accelerate clinical research by enabling cell-resolved and spatially resolved insights at scale at earlier in the research pipeline.

A targeted Clinician Researcher Accelerator Program designed to support medically qualified clinician researchers in generating high-impact spatial and single-cell data, with dedicated support and preferential pricing to fast-track translational research.

The Clinician Researcher Accelerator Program is a limited-time initiative supporting medically qualified clinician researchers who are looking to integrate spatial transcriptomics and single-cell profiling into their research. Successful applicants will receive access to dedicated technical guidance, and preferential pricing to help generate robust pilot data for translational and clinically focused studies.

Many clinical samples including tumours, immune tissues, and biopsies, are highly heterogeneous. Bulk profiling averages signals across cell populations, obscuring rare or disease-driving cell states.

Chromium Single Cell technologies enable researchers to:

• Identify rare or pathogenic cell populations
• Characterise immune cell diversity and activation states
• Study patient-to-patient variability at cellular resolution

Clinical impact:
Earlier identification of clinically relevant subpopulations improves hypothesis generation, patient stratification strategies, and biomarker discovery.

Understanding where cells are located within tissue is critical for clinical interpretation, particularly in oncology, immunology, and pathology-driven research.

Visium Spatial Gene Expression allows researchers to:

• Map gene expression within intact tissue sections
• Correlate molecular patterns with histology
• Identify spatially distinct disease niches

Clinical impact:
Spatial context strengthens biological interpretation, supports translational relevance, and enables more compelling mechanistic narratives for grants and publications.

Discovery technologies are most powerful when paired with targeted validation in clinically relevant samples.

Xenium In Situ enables:

• High-plex, single-cell resolution spatial validation
• Direct visualisation of clinically relevant gene signatures
• Confirmation of biomarkers within preserved tissue architecture

Clinical impact:
Xenium supports the transition from discovery to validation which is a critical step for translational studies, diagnostic development, and clinical adoption.

Clinical research is often constrained by:

• Limited sample availability
• Ethical and governance considerations
• The need to justify scale and cost upfront

10x Genomics platforms are well suited to small, high-information pilot studies, allowing researchers to:

• De-risk experimental design
• Generate convincing preliminary data
• Strengthen ARC, NHMRC, and translational grant applications

Clinical impact:
High-quality pilot data reduces uncertainty and accelerates progression to larger, funded studies.

Complex clinical questions rarely have single-dimensional answers.

10x Genomics workflows support:

• Integration of transcriptomics, immune profiling, and spatial biology
• Cross-platform studies linking cell state, location, and function
• More comprehensive biological models of disease

Clinical impact:
Multi-modal data improves robustness, reproducibility, and translational relevance which is increasingly expected by reviewers and collaborators.

Clinical research demands consistency, robustness, and scalability.

10x Genomics technologies are:

• Highly standardised and widely adopted
• Supported by validated workflows and protocols
• Designed for reproducible data generation across sites

Clinical impact:
Standardisation supports multi-centre studies and facilitates collaboration between hospitals, academia, and industry.

Graduate students and early to mid-career researchers with no prior hands-on experience using 10x Genomics technologies are invited to apply for the prestigious 2026 Millennium Science – 10x Genomics Fellowship Program.
This Fellowship is designed to support researchers who are keen to adopt cutting-edge single-cell and spatial technologies in their work.

Applications close: 16 March 2026
Outcomes announced: 30 March 2026

The 2026 Fellowship Program focuses on the application of 10x Genomics technologies to FFPE samples, using one or more of the following platforms:
Chromium Single Cell
Visium Spatial 
Xenium In Situ  (NEW within the Fellowship Program!)

If you have any questions, please contact us at fellowship@mscience.com.au.

Flow cytometry has long been the backbone of high-dimensional single-cell analysis. With the ability to measure up to ~45 parameters per cell, flow has enabled researchers and core facilities to rapidly phenotype complex populations and enrich rare cell types with confidence.

But what if you could go further — without disrupting your existing workflows?

By integrating flow cytometry with single-cell sequencing, researchers can now move beyond predefined panels and surface markers to uncover deeper, unbiased biological insight.

Flow cytometry has long been the gold standard for measuring what you expect to see. But what about the biology you don’t expect? What about the rare cell states, subtle activation programs, and novel biomarkers that surface markers alone simply can’t capture?

This is where single-cell sequencing transforms your capabilities. By bridging flow cytometry with the 10x Genomics platform, you can move from measuring dozens of parameters to profiling 300+ protein markers—with the option to simultaneously capture whole-transcriptome gene expression from the same single cell.

Unmatched multiplexing without compromise
Breaking free from spectral overlap limitations opens new possibilities. Instead of carefully balancing fluorophore combinations, you can now interrogate hundreds of protein markers alongside comprehensive gene expression data. This quantum leap in multiplexing reveals cellular complexity that traditional flow simply cannot access.

Discovering What’s Hidden
Many critical cell states appear identical by surface protein analysis alone. Activation, exhaustion, differentiation, and stress states often require deeper molecular investigation to truly distinguish. Single-cell sequencing uncovers these hidden layers of heterogeneity, revealing novel populations and functional states that would otherwise remain invisible.

Deeper biology from enriched populations
Leverage FACS to isolate rare or complex populations, then apply single-cell sequencing to achieve transcriptome-wide and high-plex proteomic resolution.In short: sort with flow, then profile with depth.

Designed for Your Workflow

The beauty of this approach is that it builds on what you already do exceptionally well. Use FACS to enrich the rare or complex populations you’re interested in, then apply single-cell sequencing to achieve transcriptome-wide resolution. Your expertise in flow cytometry becomes the foundation for even more powerful discoveries.

By pairing flow cytometry with single-cell sequencing, researchers can access a new layer of biological resolution:

• Unbiased cell type and state discovery
  Identify known and novel populations without relying on predefined antibody panels.

• Protein validation with gene expression
  Confirm antibody signals and distinguish protein presence from true pathway activation.

• Functional state resolution beyond surface markers
  Dissect activation, exhaustion, differentiation and stress states that appear identical by flow.

• Pathway-level biology at scale
  Interrogate canonical pathways such as Wnt, TCR and interferon signalling through coordinated gene expression, rather than single proxy markers.

With the introduction of Single Cell Flex v2.0 (Protein-Only), high-plex single-cell protein profiling is now more accessible than ever.

This flexible option enables:

• High-plex protein analysis at a significantly reduced cost

• Support for more projects, more users and more samples

• No requirement for RNA profiling, where transcriptomics isn’t needed

For many flow cores, this opens the door to offering advanced single-cell services without the overhead of full transcriptome assays.

The integration of 10x Genomics technology with your existing flow cytometry services doesn’t mean disrupting established workflows—it means enhancing them. Your team’s expertise in high-dimensional single-cell analysis positions you perfectly to take this next step.

As the authorised 10x Genomics distributor in Australia and New Zealand, Millennium Science is here to help you understand how single-cell sequencing can complement and extend your current offerings. Whether you’re looking to add new capabilities, support cutting-edge research, or simply explore what’s possible beyond traditional flow, our specialists are ready to guide you through the options.

To help us meet your delivery requirements before the Christmas break, please note the following important dates: 

• For general consumable items: Place your order by 12 PM, Wednesday 26 November 2025.
• For 10x Genomics consumables: Place your order by 4 PM, Monday 1 December 2025.
• Instrument delivery times will be provided on a case-by-case basis.

• Our office will close at 12 PM on Tuesday 23 December 2025 and reopen on Friday 2 January 2026. 

• No orders will be processed during the office closure. 

• The Millennium Science warehouse’s final shipping day will be Wednesday 17 December 2025, resuming dispatches on Monday 5 January 2026. 

Thank you for your continued support throughout 2025. We wish you a safe and joyful holiday season! 

Please note: These dates are subject to product availability and the delivery facilities at your institution being operational. 

When it comes to multiplex protein analysis, researchers need accuracy, speed, and simplicity. Traditional flow-based systems have long been the standard, but they bring challenges: sheath fluids, blocked probes, and constant maintenance. Enter the Mabtech EYRA™ – a fluidics-free multiplex immunoassay platform that reimagines how scientists generate cytokine and biomarker data. With confocal imaging, RAWsphere analysis, and compatibility with EYRAplex bead kits, EYRA makes multiplexing faster, simpler, and more reliable.

With EYRAplex magnetic bead assays, EYRA can quantify more than 30 analytes from a single sample – whether that’s serum, plasma, or cell culture supernatant. This means less sample consumption, fewer runs, and richer datasets for every experiment.

At the core of EYRA’s precision is the RAWsphere image analysis algorithm. It identifies each bead, links it to the correct analyte, and quantifies the PE signal with high resolution. Whether you’re measuring six cytokines or a full 30+ panel, RAWsphere ensures your multiplex data is accurate and reproducible.

EYRA is built around a completely flow-free design. No sheath fluid, priming, waste handling or blocked probes.

Instead of pushing samples through fluidics, EYRA uses confocal microscopy to image settled magnetic beads directly in the wells of a 96-well plate. Each bead carries a unique fluorescent dye signature for identification, while analyte-bound PE-labelled antibodies provide the quantitative signal.

The result? You insert your plate, select your assay in the intuitive Mabtech Opal™ software, and hit read. Fifteen minutes later, you have fully processed data – with your samples never leaving the wells.

Opal™ software comes preloaded with templates for every EYRAplex kit. Standards, plate layouts, and gating are handled automatically – so you spend less time setting up and more time on results.

Once the plate read is complete, results are exported directly into Excel, with options for bulk export if you’re working on large studies or multiple plates. No manual reformatting. No data wrangling headaches.

Because EYRA is fluidics-free, there’s no daily calibration or cleaning. No flushing, no wasted consumables, and no time lost to instrument downtime. It’s genuinely a plug-and-play experience – switch it on, run your plate, and walk away with your data.

The Mabtech EYRA isn’t just another multiplex platform – it’s multiplexing reimagined. By removing fluidics and harnessing high-resolution confocal imaging, EYRA delivers:

• High-plex capacity: 30+ analytes per well
• Fast turnaround: ~15 minutes per plate
• No maintenance: no daily cleaning or calibration
• Accurate, reproducible results: powered by RAWsphere analysis

For labs looking to streamline their workflow without sacrificing data quality, EYRA offers a fresh, frustration-free alternative to traditional flow-based systems.

Until next time… happy experimenting!

Joe Roberts, PhD
Product Manager
Millennium Science

When it comes to measuring proteins such as cytokines, antibodies, or growth factors, there’s no shortage of options. ELISA, ELISpot, and FluoroSpot all have important roles to play. While each assay relies on antibody-based detection, knowing which one to use (and when) can mean the difference between simply collecting data and gaining real insight.

As a Product Manager at Millennium Science, I speak with researchers every day who are deciding between these techniques. In this blog we will explore each assay to help you spot the difference and help you choose the right assay for your next experiment.

ELISA (Enzyme-Linked Immunosorbent Assay) is one of the most widely used immunoassays for detecting and quantifying soluble proteins, such as cytokines, antibodies, and hormones, in serum, plasma, or cell culture supernatants. It’s robust, scalable, and ideal for high-throughput analysis when you need accurate, reproducible concentration data.

How it works (Sandwich ELISA):
A capture antibody is coated onto a high-binding plate and binds the target protein in your sample. A biotinylated detection antibody binds a different epitope, followed by a streptavidin–enzyme conjugate. Addition of a colourimetric substrate produces a measurable signal proportional to protein concentration.

Why researchers choose it:

• Delivers quantitative results (e.g., pg/ml or ng/ml)
• Compatible with high-throughput and automation
• Well-established, with widely available equipment
• Ideal for comparative analysis across multiple samples

Limitations:

• No information on the number or type of cells producing the protein
• Sensitivity can be lower than single-cell assays

ELISpot (Enzyme-Linked ImmunoSpot) detects and counts cells that secrete a specific protein. It’s particularly valuable when studying immune responses where the frequency of antigen-specific T or B cells is low – for example in vaccine research, oncology, and autoimmune disease studies.

How it works:
Live immune cells are added to a PVDF plate pre-coated with a capture antibody. When stimulated, the cells secrete the target protein, which is immediately bound near the cell. After washing away cells, a detection antibody and enzyme conjugate are added. A precipitating substrate forms a visible spot at each secretion site – each spot representing a single responding cell.

Why it stands out:

• Extremely sensitive – can detect one responder cell in >100,000
• Functional readout of immune activity
• Ideal for rare antigen-specific responses
• Widely used in T-cell response monitoring, vaccine trials, allergy research, and immuno-oncology

Pairing with Mabtech’s ASTOR2 automated ELISpot reader delivers rapid, high-precision spot counting with consistent, reproducible results across entire assay plates, and when used with Mabtech monoclonal antibody pairs and ready-to-use ELISpot kits, ensures reliable performance across species and sample types.

FluoroSpot builds on the ELISpot principle but uses fluorescently labelled detection antibodies to identify multiple proteins secreted by the same cell – typically 2-4 proteins. This allows you to measure not just whether a cell responds, but how it responds.

Why it’s powerful:

• Detects polyfunctionality – cells secreting multiple cytokines
• High sensitivity with low background
• Enables simultaneous detection of different functional subsets
• Excellent for vaccine research, infectious disease, and cancer immunotherapy

Pairing with Mabtech’s IRIS2 ELISpot, FluoroSpot and FociSpot reader enables precise, high-resolution spot detection across multiple fluorescence channels.

• ELISA → When you want to know how much protein is present in a sample.
• ELISpot → When you need to know how many cells are producing a protein.
• FluoroSpot → When you need to know which protein a cell is producing, and whether it’s producing more than one at the same time.

In many projects, using ELISA and ELISpot/FluoroSpot together can give the clearest picture — combining quantitative bulk measurements with functional single-cell insights.

If you’d like help selecting the right assay for your research, get in touch with our team at Millennium Science. We’re local experts, and Mabtech’s range covers everything from research use to clinical-grade applications.

Until next time… happy experimenting!

Joe Roberts, PhD
Product Manager
Millennium Science

Norgen Biotek’s Magnetic Bead-Based Total RNA Purification Kit is now fully automated, making high-throughput RNA extraction faster, more reliable, and easier to scale.

Designed to isolate all RNA sizes – including microRNA and small RNA – with exceptional purity and reproducibility, this kit delivers consistent performance across a wide range of sample types. Whether you’re working with tissues, cells, bacteria, viruses, bodily fluids, plants or fungi, Norgen Biotek’s advanced RNA purification technology ensures high-yield results without compromising quality.

Manual RNA extraction can be labour-intensive and prone to variability. Norgen Biotek’s magnetic bead-based kit streamlines the process, reducing hands-on time to just 15 minutes, while enhancing consistency across runs.

This kit is fully compatible with leading lab automation platforms, including:

• Opentrons Flex – a modular and cost-effective automation system designed to scale with your lab.

• Tecan

• Thermo Fisher KingFisher

• Hamilton

• IsoPure

Seamless integration allows labs to boost throughput, minimise human error, and free up valuable time for high-value analysis and discovery.

✅ Compatible with a broad range of sample types
✅ High-quality RNA including microRNA and small RNA
✅ Automation-ready for reliable scalability
✅ Reduced hands-on time and increased reproducibility

Explore how Norgen Biotek and Opentrons can modernise your lab’s RNA extraction today or contact Narisa Dawar our Norgen Biotek Product Manager – ndawar@mscience.com.au.

MedChemExpress (MCE) is a supplier of high-quality chemicals, biochemicals and compound libraries, supporting the global scientific research community. MCE’s extensive product portfolio includes a range of screening libraries designed to accelerate drug discovery and development across multiple therapeutic areas. Among these, the Anti-Cancer Compound Library is a powerful tool for researchers seeking targeted solutions and novel cancer therapies.

The library offers over 8,000 compounds with activity against both solid and haematologic tumours, making it suitable for high-throughput screening (HTS) and high-content screening (HCS).

This collection spans key cancer-related pathways such as apoptosis, cell cycle regulation and signal transduction. It also covers diverse signalling pathways — including kinase, GPCR and epigenetics — providing researchers with a comprehensive platform to explore and identify potential anti-cancer agents.

Many of the compounds have undergone rigorous clinical or preclinical evaluations, with some already approved by the FDA, highlighting their therapeutic potential.

The bioactivity and safety profiles of the compounds make the library a useful resource for advancing cancer research. Each compound is also validated for high purity and quality using NMR and LC/MS techniques, which should lead to precise and reproducible results.

A key advantage of MCE’s compound libraries is that users can fully customise a library to meet research needs from the type, quantity and concentrations of compounds and layout, offering the flexibility that researchers need to drive meaningful discoveries in oncology.

Click here to download the MedChemExpress Compounding Libraries brochure or contact Millennium Science at customerservice@mscience.com.au.

The rapid and accurate detection of bacteria in aquatic environments has typically been challenging due to the complexity of the natural water microbial populations. Traditional agar plate methods for analysing aquatic bacteria are subjective and laborious, and rely on being able to adequately culture bacteria.

The good news is, flow cytometers with a high sensitivity of detection provide tools for detecting and analysing microbes independent of their cultivability, as the size, number, nucleic acid content, activity and classification of bacteria can be derived from scattered light and fluorescence signals using flow cytometry. The Agilent NovoCyte flow cytometer can detect very small particles (down to 0.1 µm) with high sensitivity, and so can be applied to various microbial studies by combining multiparameter analytic capability and convenient fluidic maintenance.

In testing the flow cytometer’s capabilities, water samples from multiple environment waters were stained with either SYBR Green I or SYTOX Green I; both are fluorescent dyes which bind to nucleic acids. The instrument was cleaned prior to running samples, filtered buffers were used, and an unstained sample was run to distinguish background noise from fluorescent signal and appropriate scatter and fluorescent thresholding was undertaken.

Using the NovoCyte flow cytometer, the bacteria in natural water could be differentiated into two groups: bacteria of low nucleic acid content (LNA) and of high nucleic acid content (HNA) (Figure 1). It is broadly accepted that HNA is active bacteria, whereas LNA is inactive, dead or a dormant population.

Figure 1: Detection of bacteria in natural waters.

Total bacterial cell counts in multiple environmental waters was also quantified using the NovoCyte flow cytometer (see Table 1). Results demonstrated that natural waters contained the highest bacterial counts of the samples tested and bottled water the lowest. Furthermore, bacterial counts in still water were 10 to 100x higher than that of spring and mountain stream sources.

Table 1: Total cell counts of bacteria in various water samples.

The detection of bacteria in various water samples is essential to maintaining sanitary and healthy drinking conditions, and the NovoCyte flow cytometer can easily and efficiently detect and quantify bacteria in water from several sources. With detection sensitivity coupled to the automatic cell counts measured for each sample, the NovoCyte is an efficient instrument for this application.

Top image credit: iStock.com/stock_colors

This article was initially published in Lab+Life Scientist.